TWC
FHTX icon

TD Waterhouse Canada’s Foghorn Therapeutics FHTX Stock Holding History

TD Waterhouse Canada’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.01K Buy
+1,000
New +$4.44K ﹤0.01% 1977

Other funds holding FHTX

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
BFS
Bare Financial Services Gap, Pennsylvania $436M AUM 20.22% 1-Year Est. Return

TD Waterhouse Canada's FHTX Position: Q2 2026 in Review

TD Waterhouse Canada opened a new position in Foghorn Therapeutics (FHTX) in Q2 2026: 1,000 shares worth $5.01K. The stake represents ﹤0.01% of the portfolio and ranks #1977 among its holdings.

18 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • TD Waterhouse Canada held 1,000 shares of Foghorn Therapeutics worth $5.01K as of Q2 2026.
  • Foghorn Therapeutics was a new TD Waterhouse Canada position in Q2 2026.
  • Foghorn Therapeutics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1977 holding.
  • 18 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.